Scientists devise new strategy to design antibody-based HIV vaccineJune 15th, 2009 - 4:46 pm ICT by ANI
Washington, June 15 (ANI): In their battle against AIDS, scientists have come up with a new strategy for the development of an antibody-based HIV vaccine.
According to Dr. John R. Mascola, the Deputy Director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, recent studies have worked towards creating a vaccine that induces antibodies that prevent HIV infection or disease.
The studies have shown that, contrary to widespread belief, it is not uncommon for people infected with HIV to naturally make antibodies that can neutralize a variety of HIV strains.
The antibodies do not protect people from the virus because they arise years after HIV infection is established.
However, if a vaccine could prime the body to make these broadly neutralizing antibodies before exposure to HIV, it could be possible to prevent infection or hold the virus at bay until a large number of immune cells accumulate to control viral replication.
Thus, based on these findings, the researchers have recommended a research strategy that uses naturally occurring, broadly neutralizing anti-HIV antibodies for the ultimate design of an antibody-based HIV vaccine.
One of the biggest aspects of this strategy is to obtain new broadly neutralizing antibodies to HIV to expand the pool available for scientists to study.
The researchers need to identify regions on the surface of HIV that are vulnerable to broadly neutralizing antibodies, and determine the atomic-level crystal structure of those regions.
Besides, they aim to understand how broadly neutralizing antibodies to HIV evolve and persist.
The scientists will also clarify the structural differences between anti-HIV antibodies that do and do not have neutralizing properties.
They would determine what quantity of broadly neutralizing antibodies an HIV vaccine must elicit to be effective.
With the new strategy, the researchers would aim to learn how anti-HIV neutralizing antibodies and HIV surface proteins evolve in response to one another in people who eventually produce a powerful neutralizing antibody response to the virus.
Their findings are expected to clarify how HIV surface proteins are presented to the immune cells that produce broadly neutralizing antibodies to HIV.
Besides, they would determine what immune system conditions promote the production of broadly neutralizing anti-HIV antibodies. (ANI)
- Antibodies that prevent HIV from infecting human cells found - Jul 09, 2010
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine - Jul 09, 2010
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Effective antibodies against flu strains identified - Aug 10, 2012
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Structure of immune molecule that counteracts HIV strains determined - Jun 02, 2010
- Tweaking antibody could lead to vaccine against HIV - May 08, 2011
- Scientists tame HIV by stripping it of cholesterol - Sep 29, 2011
- Why so many antibodies turn out to be ineffective in blocking HIV infection - Nov 19, 2010
- Why decades-long AIDS vaccine search hasn't been fruitful - Apr 23, 2009
- Biological catch-22 prevents generation of HIV blocking antibodies - Dec 16, 2009
Tags: allergy, antibody, atomic level, crystal structure, deputy director, dr john, hiv, hiv antibodies, hiv infection, hiv strains, hiv vaccine, immune cells, infectious diseases, national institute of allergy and infectious diseases, neutralizing antibodies, new strategy, research strategy, ultimate design, vaccine research center, viral replication